These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 24237177)

  • 1. Comparison of primary vaccination regimes for equine influenza: working towards an evidence-based regime.
    Cullinane A; Gildea S; Weldon E
    Equine Vet J; 2014 Nov; 46(6):669-73. PubMed ID: 24237177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of antibody responses to commercial equine influenza vaccines following primary vaccination of Thoroughbred weanlings--a randomised blind study.
    Gildea S; Arkins S; Walsh C; Cullinane A
    Vaccine; 2011 Nov; 29(49):9214-23. PubMed ID: 21983355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Humoral response and antiviral cytokine expression following vaccination of thoroughbred weanlings--a blinded comparison of commercially available vaccines.
    Gildea S; Quinlivan M; Murphy BA; Cullinane A
    Vaccine; 2013 Oct; 31(45):5216-22. PubMed ID: 24021309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of antibody responses to commercial equine influenza vaccines following annual booster vaccination of National Hunt horses - a randomised blind study.
    Gildea S; Arkins S; Walsh C; Cullinane A
    Vaccine; 2011 May; 29(22):3917-22. PubMed ID: 21419776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated vaccination schedule provides protective levels of antibody and complete herd immunity to equine influenza.
    El-Hage CM; Savage CJ; Minke JM; Ficorilli NP; Watson J; Gilkerson JR
    Equine Vet J; 2013 Mar; 45(2):235-9. PubMed ID: 22943193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influential factors inducing suboptimal humoral response to vector-based influenza immunisation in Thoroughbred foals.
    Fougerolle S; Legrand L; Garrett D; Birand I; Foursin M; D'Ablon X; Bayssat P; Newton RJ; Pronost S; Paillot R
    Vaccine; 2016 Jul; 34(33):3787-95. PubMed ID: 27269055
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a benefit from an early booster vaccination in the control of equine influenza?
    Heldens JG; van Loon AA; van de Zande S
    Vet J; 2007 Nov; 174(3):592-8. PubMed ID: 17560150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection, systemic IFNgamma, and antibody responses induced by an ISCOM-based vaccine against a recent equine influenza virus in its natural host.
    Paillot R; Grimmett H; Elton D; Daly JM
    Vet Res; 2008; 39(3):21. PubMed ID: 18252187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Field studies on equine influenza vaccination regimes in thoroughbred foals and yearlings.
    Cullinane A; Weld J; Osborne M; Nelly M; Mcbride C; Walsh C
    Vet J; 2001 Mar; 161(2):174-85. PubMed ID: 11243687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibody responses after vaccination against equine influenza in the Republic of Korea in 2013.
    Kim EJ; Kim BH; Yang S; Choi EJ; Shin YJ; Song JY; Shin YK
    J Vet Med Sci; 2015 Nov; 77(11):1517-21. PubMed ID: 26062436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of different equine influenza vaccine products and other factors on equine influenza antibody levels in Thoroughbred racehorses.
    Ryan M; Gildea S; Walsh C; Cullinane A
    Equine Vet J; 2015 Nov; 47(6):662-6. PubMed ID: 25238593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Whole inactivated equine influenza vaccine: Efficacy against a representative clade 2 equine influenza virus, IFNgamma synthesis and duration of humoral immunity.
    Paillot R; Prowse L; Montesso F; Huang CM; Barnes H; Escala J
    Vet Microbiol; 2013 Mar; 162(2-4):396-407. PubMed ID: 23146168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of a novel cold-adapted modified-live equine influenza virus vaccine.
    Tabynov K; Kydyrbayev Z; Ryskeldinova S; Assanzhanova N; Kozhamkulov Y; Inkarbekov D; Sansyzbay A
    Aust Vet J; 2014 Nov; 92(11):450-7. PubMed ID: 25348146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.
    Breathnach CC; Clark HJ; Clark RC; Olsen CW; Townsend HG; Lunn DP
    Vaccine; 2006 Feb; 24(8):1180-90. PubMed ID: 16194586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of the protective immune response after prime and booster vaccination of yearlings with a live modified cold-adapted viral vaccine against equine influenza.
    Tabynov K; Kydyrbayev Zh; Ryskeldinova Sh; Assanzhanova N; Sansyzbay A
    Vaccine; 2014 May; 32(25):2965-71. PubMed ID: 24726250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evaluation of a nucleoprotein ELISA for the detection of equine influenza antibodies and the differentiation of infected from vaccinated horses (DIVA).
    Galvin P; Gildea S; Arkins S; Walsh C; Cullinane A
    Influenza Other Respir Viruses; 2013 Dec; 7 Suppl 4(Suppl 4):73-80. PubMed ID: 24224822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of immunity induced by an equine influenza and tetanus combination vaccine formulation adjuvanted with ISCOM-Matrix.
    Heldens JG; Pouwels HG; Derks CG; Van de Zande SM; Hoeijmakers MJ
    Vaccine; 2010 Oct; 28(43):6989-96. PubMed ID: 20728523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of a systemic prime/mucosal boost strategy with an equine influenza ISCOM vaccine to induce protective immunity in horses.
    Crouch CF; Daly J; Henley W; Hannant D; Wilkins J; Francis MJ
    Vet Immunol Immunopathol; 2005 Dec; 108(3-4):345-55. PubMed ID: 16098611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Evaluation of Three Different Primary Equine Influenza Vaccination Intervals in Foals.
    Dilai M; Fassi Fihri O; El Harrak M; Bouchiba A; Dehhaoui M; Mahir W; Dikrallah A; Legrand L; Paillot R; Piro M
    J Equine Vet Sci; 2021 Apr; 99():103397. PubMed ID: 33781435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the response to an accelerated immunisation schedule using a canarypox-vectored equine influenza vaccine, shortened interdose intervals and vaccination of young foals.
    Minke JM; El-Hage CM; Tazawa P; Homer D; Lemaitre L; Cozette V; Gilkerson JR; Kirkland PD
    Aust Vet J; 2011 Jul; 89 Suppl 1():137-9. PubMed ID: 21711312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.